{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T08:15:57Z","timestamp":1780992957738,"version":"3.54.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"SRM-DBT Partnership Platform"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.imbio.2018.07.020","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T10:32:42Z","timestamp":1532082762000},"page":"718-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines"],"prefix":"10.1016","volume":"223","author":[{"given":"Dhamodharan","family":"Umapathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sireesh","family":"Dornadula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezhilarasi","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vairamani","family":"Mariappanadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-4896","authenticated-orcid":false,"given":"Kunka Mohanram","family":"Ramkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imbio.2018.07.020_bib0005","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1038\/s41598-017-02421-9","article-title":"Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients","volume":"7","author":"Al-Rubeaan","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.imbio.2018.07.020_bib0010","first-page":"7","article-title":"Association of hs-CRP with diabetic and non-diabetic individuals","volume":"3","author":"Amanullah","year":"2010","journal-title":"Jordan J. Biol. Sci. (JJBS)"},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0015","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.2337\/dc07-1960","article-title":"Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate","volume":"31","author":"Astrup","year":"2008","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0020","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.4049\/jimmunol.1400874","article-title":"RelB\/p50 complexes regulate cytokine-induced YKL-40 expression","volume":"194","author":"Bhardwaj","year":"2015","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2362.2010.02446.x","article-title":"YKL-40 in type 2 diabetic patients with different levels of albuminuria","volume":"41","author":"Brix","year":"2011","journal-title":"Eur. J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.imbio.2018.07.020_bib0030","first-page":"177","article-title":"C-reactive protein and chitinase 3-like protein 1 as biomarkers of spatial redistribution of retinal blood vessels on digital retinal photography in patients with diabetic retinopath","volume":"14","author":"Cekic","year":"2014","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4239\/wjd.v5.i6.763","article-title":"Biomarkers in diabetic nephropathy: Present and future","volume":"5","author":"Currie","year":"2014","journal-title":"World J. Diabetes"},{"issue":"5","key":"10.1016\/j.imbio.2018.07.020_bib0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11906-010-0133-3","article-title":"Is the presence of microalbuminuria a relevant marker of kidney disease?","volume":"12","author":"Glassock","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"issue":"4","key":"10.1016\/j.imbio.2018.07.020_bib0045","doi-asserted-by":"crossref","first-page":"18596","DOI":"10.4238\/2015.December.28.7","article-title":"Correlation between serum YKL-40 levels and albuminuria in type 2 diabetes","volume":"14","author":"Han","year":"2015","journal-title":"Genet. Mol. Res."},{"issue":"4","key":"10.1016\/j.imbio.2018.07.020_bib0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1200\/JCO.2008.18.8367","article-title":"Elevated plasma YKL-40 predicts increased risk of gastrointestinal cancer and decreased survival after any cancer diagnosis in the general population","volume":"27","author":"Johansen","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.imbio.2018.07.020_bib0055","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehp049","article-title":"High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease","volume":"30","author":"Kastrup","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.imbio.2018.07.020_bib0060","doi-asserted-by":"crossref","first-page":"35282","DOI":"10.1038\/srep35282","article-title":"Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"6","author":"Kumagai","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.imbio.2018.07.020_bib0065","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1084\/jem.20081271","article-title":"Role of breast regression protein 39 (BRP-39)\/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis","volume":"206","author":"Lee","year":"2009","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.imbio.2018.07.020_bib0070","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jdiacomp.2012.04.012","article-title":"Clinical implication of plasma and urine YKL-40, as a proinflammatory biomarker, on early stage of nephropathy in type 2 diabetic patients","volume":"26","author":"Lee","year":"2012","journal-title":"J. Diabetes Complicat."},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0075","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann. Internal Med."},{"key":"10.1016\/j.imbio.2018.07.020_bib0080","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1111\/j.1523-1755.2004.09215.x","article-title":"Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease","volume":"92","author":"Mann","year":"2004","journal-title":"Kidney Int. Suppl."},{"issue":"3","key":"10.1016\/j.imbio.2018.07.020_bib0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/dmrr.1068","article-title":"Urinary biomarkers involved in type 2 diabetes: a review","volume":"26","author":"Matheson","year":"2010","journal-title":"Diabetes\/Metab. Res. Rev."},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0090","first-page":"655","article-title":"Serum YKL-40 levels in rheumatoid arthritis: correlations between clinical and laborarory parameters","volume":"19","author":"Matsumoto","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.imbio.2018.07.020_bib0095","first-page":"12","article-title":"Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus","volume":"3","author":"Mojahedi","year":"2009","journal-title":"Iran. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.imbio.2018.07.020_bib0100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonzalez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"11","key":"10.1016\/j.imbio.2018.07.020_bib0105","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.2337\/db08-0182","article-title":"Plasma YKL-40: a BMI-independent marker of type 2 diabetes","volume":"57","author":"Nielsen","year":"2008","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.imbio.2018.07.020_bib0110","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cyto.2011.03.014","article-title":"IL-6, but not TNF-alpha, increases plasma YKL-40 in human subjects","volume":"55","author":"Nielsen","year":"2011","journal-title":"Cytokine"},{"issue":"11","key":"10.1016\/j.imbio.2018.07.020_bib0115","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/eurheartj\/ehl448","article-title":"N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population","volume":"28","author":"Olsen","year":"2007","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.imbio.2018.07.020_bib0120","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1586\/1744666X.4.3.379","article-title":"C-reactive protein at the interface between innate immunity and inflammation","volume":"4","author":"Peisajovich","year":"2008","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2018.07.020_bib0125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00011-005-0010-8","article-title":"YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance","volume":"55","author":"Rathcke","year":"2006","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.imbio.2018.07.020_bib0130","series-title":"The Inflammation Marker YKL-40 Is Elevated in Patients With Type 2 Diabetes and Is Associated With an Increased Mortality Rate in Normal Individuals after Adjustment for Risk Factors of Cardiovascular Events. Diabetologia","year":"2007"},{"issue":"2","key":"10.1016\/j.imbio.2018.07.020_bib0135","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/dc08-1144","article-title":"YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria","volume":"32","author":"Rathcke","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.imbio.2018.07.020_bib0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijcard.2009.01.043","article-title":"Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population","volume":"143","author":"Rathcke","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.imbio.2018.07.020_bib0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2840-10-54","article-title":"YKL-40 levels are independently associated with albuminuria in type 2 diabetes","volume":"10","author":"Rondbjerg","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.imbio.2018.07.020_bib0150","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.ijbiomac.2017.10.078","article-title":"Increased levels of circulating (TNF-alpha) is associated with (-308G\/A) promoter polymorphism of TNF-alpha gene in Diabetic Nephropathy","volume":"107","author":"Umapathy","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.imbio.2018.07.020_bib0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/1354750X.2014.992475","article-title":"Proteins from the 18 glycosyl hydrolase family are associated with kidney dysfunction in patients with diabetes type 2","volume":"20","author":"Zurawska-Plaksej","year":"2015","journal-title":"Biomarkers"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298518300639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298518300639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:45:36Z","timestamp":1759250736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298518300639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0171298518300639"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2018.07.020","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"YKL-40: A biomarker for early nephropathy in type 2 diabetic patients and its association with inflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2018.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}]}}